Network modeling of kinase inhibitor polypharmacology reveals pathways targeted in chemical screens

作者: Oana Ursu , Sara J. C. Gosline , Neil Beeharry , Lauren Fink , Vikram Bhattacharjee

DOI: 10.1371/JOURNAL.PONE.0185650

关键词: EpigeneticsBiologyGemcitabineDNA repairPancreatic cancerTranscription factorComputational biologyKinaseMode of actionSmall molecule

摘要: Small molecule screens are widely used to prioritize pharmaceutical development. However, determining the pathways targeted by these molecules is challenging, since compounds often promiscuous. We present a network strategy that takes into account polypharmacology of small in order generate hypotheses for their broader mode action. report screen kinase inhibitors increase efficacy gemcitabine, first-line chemotherapy pancreatic cancer. Eight emerge known affect 201 kinases, which only three kinases have been previously identified as modifiers gemcitabine toxicity. In this work, we use SAMNet algorithm identify linking and genetic toxicity with transcriptional epigenetic changes induced measure using DNaseI-seq RNA-seq. uses constrained optimization connect genes from complementary datasets through set protein-protein protein-DNA interactions. The resulting recapitulates including DNA repair, cell proliferation epithelial-to-mesenchymal transition. predict important roles response, six already shown modify cancer ten novel candidates. Our work reveals role activity chemosensitizing agents.

参考文章(58)
Doriano Fabbro, Sandra W. Cowan-Jacob, Henrik Möbitz, Georg Martiny-Baron, Targeting cancer with small-molecular-weight kinase inhibitors. Methods of Molecular Biology. ,vol. 795, pp. 1- 34 ,(2012) , 10.1007/978-1-61779-337-0_1
Heidi Griesmann, Stefanie Ripka, Moritz Pralle, Volker Ellenrieder, Sandra Baumgart, Malte Buchholz, Christian Pilarsky, Daniela Aust, Thomas M. Gress, Patrick Michl, WNT5A-NFAT Signaling Mediates Resistance to Apoptosis in Pancreatic Cancer Neoplasia. ,vol. 15, pp. 11- 22 ,(2013) , 10.1593/NEO.121312
Shao-shan Carol Huang, David C. Clarke, Sara J. C. Gosline, Adam Labadorf, Candace R. Chouinard, William Gordon, Douglas A. Lauffenburger, Ernest Fraenkel, Linking Proteomic and Transcriptional Data through the Interactome and Epigenome Reveals a Map of Oncogene-induced Signaling PLoS Computational Biology. ,vol. 9, pp. e1002887- ,(2013) , 10.1371/JOURNAL.PCBI.1002887
Adam S Crystal, Alice T Shaw, Lecia V Sequist, Luc Friboulet, Matthew J Niederst, Elizabeth L Lockerman, Rosa L Frias, Justin F Gainor, Arnaud Amzallag, Patricia Greninger, Dana Lee, Anuj Kalsy, Maria Gomez-Caraballo, Leila Elamine, Emily Howe, Wooyoung Hur, Eugene Lifshits, Hayley E Robinson, Ryohei Katayama, Anthony C Faber, Mark M Awad, Sridhar Ramaswamy, Mari Mino-Kenudson, A John Iafrate, Cyril H Benes, Jeffrey A Engelman, None, Patient-derived models of acquired resistance can identify effective drug combinations for cancer Science. ,vol. 346, pp. 1480- 1486 ,(2014) , 10.1126/SCIENCE.1254721
Oliver Hantschel, Unexpected off-targets and paradoxical pathway activation by kinase inhibitors. ACS Chemical Biology. ,vol. 10, pp. 234- 245 ,(2015) , 10.1021/CB500886N
Gareth J. Williams, Susan P. Lees-Miller, John A. Tainer, Mre11–Rad50–Nbs1 conformations and the control of sensing, signaling, and effector responses at DNA double-strand breaks DNA Repair. ,vol. 9, pp. 1299- 1306 ,(2010) , 10.1016/J.DNAREP.2010.10.001
G. Wang, J. W. Barrett, M. Stanford, S. J. Werden, J. B. Johnston, X. Gao, M. Sun, J. Q. Cheng, G. McFadden, Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor Proceedings of the National Academy of Sciences of the United States of America. ,vol. 103, pp. 4640- 4645 ,(2006) , 10.1073/PNAS.0509341103
Valentin Giroux, Juan Iovanna, Jean‐Charles Dagorn, Probing the human kinome for kinases involved in pancreatic cancer cell survival and gemcitabine resistance The FASEB Journal. ,vol. 20, pp. 1982- 1991 ,(2006) , 10.1096/FJ.06-6239COM
Li Yang, Min Lin, Wen-jing Ruan, Liang-liang Dong, En-guo Chen, Xiao-hong Wu, Ke-jing Ying, Nkx2-1: a novel tumor biomarker of lung cancer Journal of Zhejiang University SCIENCE B. ,vol. 13, pp. 855- 866 ,(2012) , 10.1631/JZUS.B1100382